Proteome Sciences plc

PRM

GB0003104196

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. Other stock markets 11:35:04 2024-05-24 EDT			5-day change	1st Jan Change
3.43 ^GBX	-4.72%		-12.05%	-24.28%

05-16	Proteome Sciences promises AGM return to growth in 2024	AN
05-16	AIM WINNERS & LOSERS: Proteome Sciences eyes return to growth in 2024	AN

Proteome Sciences Provides Earnings Guidance for the Full Year of 2020

March 26, 2021 at 03:00 am

The Directors of Proteome Sciences are announced that the company now expects to report profit after tax materially higher than announced on 25 January.

Latest news about Proteome Sciences plc

Proteome Sciences promises AGM return to growth in 2024	05-16	AN
AIM WINNERS & LOSERS: Proteome Sciences eyes return to growth in 2024	05-16	AN
Proteome Sciences Wins GBP500,000 Spectrometry Services Contract in US	04-26	MT
Proteome wins GBP500,000 deal to supply mass spectrometry services	04-26	AN
AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract	04-26	AN
Thoma Bravo snaps up Darktrace for USD5 billion	04-26	AN
Proteome Sciences plc Secures Contract from US Biopharmaceutical Company	04-26	CI
Proteome Sciences shares drop as revenue plunges and swings to loss	04-10	AN
Proteome Sciences plc Reports Earnings Results for the Full Year Ended December 31, 2023	04-10	CI
Proteome Sciences Completes New US Lab Setup	01-02	MT
Proteome Sciences Announces the Completion of Installation and Setup of Equipment in Its New US Laboratory in San Diego, California	01-02	CI
Proteome Sciences says San Diego lab now fully operational	01-02	AN
AIM WINNERS & LOSERS: Totally slides again; Proteome warns on earnings	11-30	AN
Proteome Sciences shares drop as cuts annual revenue outlook	11-30	AN
Proteome Sciences sees shares surge on SysQuant service launch	23-10-02	AN
Proteome Sciences plc Announces the Launch of Sysquant® SCP, the Commercial Service for Single Cell Proteomics Using the Power of its TMTpro? Isobaric Labelling Reagents	23-10-02	CI
FTSE 100 Finishes Flat After Choppy Week	23-08-25	DJ
UK 2063 Gilt Seen Attractively Valued Ahead of Syndicated Tap	23-08-25	DJ
FTSE 100 pushes higher ahead of Fed chair speech	23-08-25	AN
AIM WINNERS & LOSERS: Panthera Resources secures litigation financing	23-08-25	AN
Proteome Sciences shares fall as swings to interim loss on costs	23-08-25	AN
Earnings Flash (PRM.L) PROTEOME SCIENCES Posts H1 Loss GBX-0.20	23-08-25	MT
Proteome Sciences plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
OnTheMarket new CFO Tom Carter starts role	23-07-04	AN
Proteome Sciences repays GBP824,400 loan in full to Vulpes	23-06-01	AN

Proteome Sciences plc is a specialist provider of contract proteomics services. The Companyâs services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-24 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
PROTEOME SCIENCES PLC	-24.28%	12.91M
ABBOTT LABORATORIES	-5.56%	181B
MEDTRONIC PLC	-0.11%	108B
BECTON, DICKINSON AND COMPANY	-6.17%	66.12B
DEXCOM, INC.	+2.64%	50.65B
CENCORA, INC.	+6.58%	43.66B
HOYA CORPORATION	+4.91%	41.3B
METTLER-TOLEDO INTERNATIONAL, INC.	+21.98%	31.6B
TERUMO CORPORATION	+14.45%	25.03B
WEST PHARMACEUTICAL SERVICES, INC.	-5.81%	24.16B